Product
T7
1 clinical trial
1 indication
Indication
HealthyClinical trial
Formulation Selection and Subsequent Optimization of Oral Formulations of BI 685509 in Healthy Male Subjects (Open-label, Randomized, Single-dose Design Study in up to Three Parts; Trial Part 1: Five-period Crossover; Optional Trial Parts 2 & 3: Fourperiod Crossover)Status: Completed, Estimated PCD: 2022-02-07